minimally invasive glaucoma surgery
Alcon to acquire Hydrus Microstent MIGS device for AU$640 million
Multinational ophthalmic company Alcon has agreed to acquire privately-owned Californian firm Ivantis – and its Hydrus Microstent minimally invasive glaucoma ...
It’s all about the (aqueous) flow
When it comes to the treatment of glaucoma, there is growing evidence to suggest that the ability to re-establish the ...
New data shows iTrack efficacy as both standalone and combined MIGS procedure
Nova Eye Medical has published two-year data for its iTrack ab-interno canaloplasty procedure, which it says showed an average reduction ...
Public MIGS funding a step closer for iTrack in Australia
Nova Eye Medical has announced an application to secure public funding for its iTrack ab-interno canaloplasty as a standalone minimally ...
Sector embraces government approval of standalone MIGS
From this month, surgeons can perform standalone minimally invasive glaucoma surgery (MIGS) under Medicare, seeing Australia become the first major ...